IL17A and breast cancer: The negative impact of IL-17 producing MAIT cells on cancer progression might suggest MAIT cells are early producers [34], highlighting a novel therapeutic avenue in cancers such as breast cancer, however further work on the observations by Zumwalde and colleague is required to elucidate a role for MAIT cells in primary breast cancer.